Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108523 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage
A Early Phase 1 study, sponsored by Healthpoint.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
NCT01108523: Clinical Trial Early Phase 1 study, sponsored by Healthpoint.
NCT01108523 is a Early Phase 1 study that was terminated before completion, run by Healthpoint. The registered enrollment target is 7 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108523, a Early Phase 1 study, was terminated before completion, sponsored by Healthpoint.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.
Interventions
- DEVICE HP828-101
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-02 |
| Phase | Early Phase 1 |
Why NCT01108523 stopped before completion
NCT01108523 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which HP828-101 is the first listed.
NCT01108523 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01108523 about?
NCT01108523 is a clinical study titled "Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage". This study evaluates HP828 in the management of moisture associated skin damage after 15 days of use.
What is the current status of trial NCT01108523?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2010-04. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01108523?
The interventions under investigation include: HP828-101 (DEVICE).
Who is sponsoring clinical trial NCT01108523?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01108523's enrollment target sits among peer trials
7 1825th of 2000 higher than 156 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia